A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/28 (2006.01) A61K 9/16 (2006.01) A61K 9/50 (2006.01) A61K 31/404 (2006.01)
Patent
CA 2417887
The invention provides a pharmaceutical composition in particulate form, suitable for oral administration, including a core containing eletriptan or a pharmaceutically acceptable salt thereof, the core being coated with a water- insoluble, permeable coating including one or more acrylic copolymer(s) containing trimethylammoniumethylmethacrylate groups, said composition being capable of achieving a sigmoidal pattern of controlled drug release. Such a pharmaceutical composition is particularly useful in the prevention of migraine recurrence.
L'invention concerne une composition pharmaceutique sous forme particulaire, adaptée à une administration par voie orale, comprenant un noyau contenant de l'élétriptan ou un sel pharmaceutiquement acceptable de celui-ci, le noyau étant enrobé d'un revêtement perméable, hydro-insoluble, comprenant des groupes triméthylammoniuméthylméthacrylate contenant un ou plusieurs copolymère(s) acrylique(s), ladite composition permettant de réaliser un modèle sigmoïde de libération commandée de médicaments. Une telle composition pharmaceutique est utile en particulier dans la prévention de la récurrence de la migraine.
de Raspide Manaud Pierre Frederic
Macrae Ross James
Walther Mathias
Pfizer Inc.
Smart & Biggar
LandOfFree
Particulate composition of eletriptan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Particulate composition of eletriptan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Particulate composition of eletriptan will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1737762